Sun, Sep 21, 2014, 6:19 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • frankfrazzano frankfrazzano Jan 28, 2013 12:17 PM Flag

    OK this is the HONEST to GOODNE$$$ truth you guys/goyls/others..

    ...I went long OPK last November at $4.20 (5000) shares and I just SOLD maybe early at 6.65-6.70range! Did I forget to TELL you?

    LOL!

    ....took Profits about $10,000+!

    after U #$%$ short it I will BUY again!

    GREAT COMPANY!!

    I like DR FROST!

    Frank

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I'll be happy to put my Amarin up against your OPK to see which one has bigger run this year from right here. You like Frost, well Amarin management has track record, too.

      Sentiment: Strong Buy

    • I tell the BOARD yesterday about my TRADE w/ OPK, NO ONE RESPONDS and NOT ONE POST PREVIOUS TO ME.... and today in the PM it goes CRAZY!

      GO FIGURE the libtards!

      244,000 shares trade 6.80 to 7.10!

      Frank

      • 1 Reply to frankfrazzano
      • BETTER SELL SOON..the CRAMER effect is UPON it!

        CEO Interview: Dr. Phillip Frost, Opko Health (OPK)

        Opko Health (OPK) is headed by Dr. Phillip Frost, who has had great success with founding and selling pharma companies, two of which he sold at rich premiums; one had gained 6,000%. Opko has risen 55% in less than three months and is a huge player in diagnostic testing. It is developing a drug to reduce nausea in chemotherapy patients and has developed a Vitamin D treatment for those with renal disease. OPK has made successful acquisitions, including Claros Diagnostics. Cramer thinks Dr. Frost and Opko have a great track record of success.

 
CLDX
14.05-0.04(-0.28%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.